Lessons from the use of aromatase inhibitors in the neoadjuvant setting

Endocrine-Related Cancer

Volumn 6, Issue 2, 1999, Pages 227-230

  Dixon, J M ^a   Love, C D B ^a   Renshaw, L ^a   Bellamy, C ^a   Cameron, D A ^a   Miller, W R ^a   Leonard, R C F ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; LETROZOLE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; MAMMOGRAPHY; MASTECTOMY; POSTMENOPAUSE; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; POSTMENOPAUSE; RECEPTORS, ESTROGEN; TAMOXIFEN; TRIAZOLES;

EID: 0033008206     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060227     Document Type: Article

References (9)

1. Anderson EDC, Forrest APM, Levack PA, Chetty U & Hawkins RA 1989 Response to endocrine manipulation and oestrogen receptor concentration in large, operable breast cancer. British Journal of Cancer 60 223-226.
2. Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Benzuoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Huffman W, Michel J, Hatschele T, Tjabbes T, Chaudri HA, Hornberger U & Trunet PF 1998 Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomised trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Journal of Clinical Oncology 16 453-461.
3. Fisher B, Brown A, Mamounas E, Constantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Nargolese R, Dimibrov N & Kavanah M 1997 Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Journal of Clinical Oncology 15 2483-2493.
4. Forouhi P, Walsh JS, Anderson TJ & Chetty U 1994 Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic therapy. British Journal of Surgery 81 223-225.
5. Hortobagyi GN, Singletary SE & McNeese MD 1996 Treatment of locally advanced and inflammatory breast cancer. In Diseases of the Breast, pp 585-599. Eds JR Harris, ME Lippman, M Morrow & S Hellman. Philadelphia: Lippincott-Raven.
6. Hunt KE, Fry DR & Bland KI 1980 Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality. American Journal of Surgery 140 339-342.
7. Keen JC, Dixon JM, Miller EP, Cameron DA, Chetty U, Hanby A, Bellamy C & Miller WR 1997 Expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer. Breast Cancer Research and Treatment 44 123-133.
8. McCarty KS Jr, Miller LS, Cox EB, Konrath J & McCarby KS Sr 1985 Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Archives of Pathology and Laboratory Medicine 109 716-721.
9. WHO Handbook for Reporting Results of Cancer Treatment (Response Criteria) 1979 Publication No. 48. WHO: Geneva.